Cancers, Vol. 13, Pages 5168: Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma

Conclusions: RS predicted worse LRR and OS in R-PDAC and worse LRR, DR, and OS in BR/LA-PDAC. This may select patients who would benefit from radiation and should be validated prospectively.

Source: Cancers - October 15, 2021 Category: Cancer & Oncology Authors: Nikhil T. Sebastian Amy Webb Kenneth W. Merrell Eugene J. Koay Adam R. Wolfe Lizhi Zhang Tyler J. Wilhite Dalia Elganainy Ryan Robb Wei Chen Jordan Cloyd Mary Dillhoff Allan Tsung Laith Abushahin Anne Noonan Terence M. Williams Tags: Article Source Type: research